Dr Andy Greenfield

Dr Greenfield was a Programme Leader in Developmental Genetics at the Medical Research Council (MRC) Harwell Institute for over 25 years and chaired its Animal Welfare and Ethical Review Board (AWERB) for 10 years. His research made use of cutting-edge genetic technologies to shed light on gene function and disease. From 2009 to 2018, he was a member of the Human Fertilisation & Embryology Authority (HFEA), and in 2014 and 2016 chaired the two expert scientific panels that assessed the safety and efficacy of mitochondrial replacement techniques. He was a member of the Nuffield Council on Bioethics (NCoB, 2014-2020) and chaired its working group that reported on ethical issues surrounding genome editing in 2016. From 2019-2020, he was a member of the National Academies of Sciences International Commission on Heritable Human Genome Editing. He was also a member of the taskforce that advised on the 2021 update to the guidelines of the International Society for Stem Cell Research (ISSCR), as well as a member of the NCoB working group that reported on the ethics of genome editing in farmed animals in 2021.

Dr Greenfield is currently a member of the Regulatory Horizons Council (RHC), the Human Tissue Authority (HTA) and an honorary research fellow at the Nuffield Department of Women’s & Reproductive Health, University of Oxford.

Register of Interests

An up-to-date record of member interests can be found on the register of interests page.